Ying Xia
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
-
- Attention Deficit Hyperactivity Disorder
Papers in
- Oncology 11
- Cancer Immunotherapy and Biomarkers 8
- Inflammatory Biomarkers in Disease Prognosis 2
-
- Lung Cancer Treatments and Mutations 4
- Co-authors
- Hong‐Li Guo (9 shared papers)Ya‐Hui Hu (7 shared papers)Feng Chen (8 shared papers)Jing Xu (6 shared papers)Jianchun Yu (8 shared papers)Yunhe Liu (9 shared papers)Wentao Li (7 shared papers)Huayu Chen (4 shared papers)
- Journals
- Biomedical Chromatography (4 papers)Frontiers in Pharmacology (4 papers)Frontiers in Psychiatry (1 paper)Contrast Media & Molecular Imaging (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- ChinaSwedenUnited States
In The Last Decade
Ying Xia
27 papers receiving 295 citations
Peers
Comparison fields: 5 of 73
- Oncology 117
- Psychiatry and Mental health 52
- Endocrine and Autonomic Systems 20
- Pediatrics, Perinatology and Child Health 53
- Immunology 55
Countries citing papers authored by Ying Xia
This map shows the geographic impact of Ying Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Xia more than expected).
Fields of papers citing papers by Ying Xia
This network shows the impact of papers produced by Ying Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Xia. The network helps show where Ying Xia may publish in the future.
Co-authors
The 25 scholars most cited alongside Ying Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 38 | |
| 2 | Phase I trial of icotinib, a novel epidermal growth factor receptor tyrosine kinase inhibitor, in Chinese patients with non-small cell lung cancer. | 2011 | 31 |
| 3 | 2020 | 26 | |
| 4 | 2021 | 26 | |
| 5 | 2022 | 19 | |
| 6 | 2021 | 17 | |
| 7 | 2022 | 16 | |
| 8 | 2021 | 16 | |
| 9 | 2022 | 12 | |
| 10 | An approach to the effect on tumors of acupuncture in combination with radiotherapy or chemotherapy. | 1986 | 12 |
| 11 | 2020 | 10 | |
| 12 | Efficacy and clinical/molecular predictors of erlotinib monotherapy for Chinese advanced non-small cell lung cancer. | 2010 | 10 |
| 13 | 2022 | 8 | |
| 14 | 2020 | 8 | |
| 15 | 2021 | 8 | |
| 16 | 2024 | 7 | |
| 17 | 2012 | 7 | |
| 18 | 2021 | 6 | |
| 19 | 2007 | 6 | |
| 20 | 2023 | 3 |
About Ying Xia
Ying Xia is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Immunology, Pediatrics, Perinatology and Child Health and Psychiatry and Mental health, having authored 27 papers that have together received 303 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Immune Cell Function and Interaction (6 papers), Lung Cancer Treatments and Mutations (4 papers), Immunotherapy and Immune Responses (4 papers), Neuroscience of respiration and sleep (3 papers), Pharmacological Effects and Toxicity Studies (2 papers), Healthcare and Venom Research (2 papers) and Inflammatory Biomarkers in Disease Prognosis (2 papers). The work is most often cited by research in Oncology (117 citations), Psychiatry and Mental health (52 citations), Endocrine and Autonomic Systems (20 citations), Pediatrics, Perinatology and Child Health (53 citations) and Immunology (55 citations). Ying Xia has collaborated with scholars based in China, Sweden and United States. Frequent co-authors include Hong‐Li Guo, Ya‐Hui Hu, Feng Chen, Jing Xu, Jianchun Yu, Yunhe Liu, Wentao Li, Huayu Chen, Mengzhao Wang and Yingjie Jia. Their work appears in journals such as Biomedical Chromatography, Frontiers in Pharmacology, Frontiers in Psychiatry, Contrast Media & Molecular Imaging and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.